open access
Risk models that incorporate both BRCA1 and BRCA2
mutations and other sources of variation are required to provide
accurate estimates of mutation carrier probabilities and
cancer risk for use in genetic
counselling. Existing risk-prediction models for familial OvC such as
Breast and Ovarian Analysis
of Disease Incidence and Carrrier
Estimation Algorithm (BOADICEA) or BRCAPRO3 ,4 assume that all familial aggregation to OvC is due to BRCA1 and BRCA2
mutations but this does not reflect our understanding of OvC genetic
susceptibility. As a consequence, these models may underestimate
OvC risks in women without mutations in
these genes. Therefore, how to counsel women with family history of OvC
but without
BRCA1 or BRCA2 mutations has remained a major unresolved question in clinical cancer genetics.....
No comments:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.